|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 2100 PENNSYLVANIA AVENUE, NW |
Address2 | SUITE 500 |
City | WASHINGTON |
State | DC |
Zip Code | 20037 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 12675-24
|
||||||||
|
6. House ID# 318110010
|
TYPE OF REPORT | 8. Year | 2011 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Michael S. Berman, President |
Date | 04/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Implementation of Patient Protection and Affordable Health Care Acts (PL 111-148/PL 111-152) - Executive Branch actions re this issue.
Repeal Patient Protection and Affordable Health Care Acts (PL 111-148/PL 111-152) - HR 2, Repealing the Job-Killing Health Care Law Act;
S 223, FAA Air Transportation Modernization and Safety Improvement Act (HR 2 offered as amendment); S 192, Repealing the Job-Killing Health Care Law Act.
Proposed changes to Patient Protection and Affordable Health Care Acts (PL 111-148/PL 111-152), including repeal of individual mandate; Amicus brief - Proposed legislation re these issues.
Management of medical fraud in the private market - Proposed legislation re this issue.
*Funding for HHS programs and agencies - HJRes 44, Further Continuing Appropriations Amendments, 2011; HJRes 48, Additional Continuing Appropriations Amendments, 2011; HR 1, Full-Year Continuing Appropriations Act, 2011.
*Repeal of Form 1099 provision - HR 4, Comprehensive 1099 Taxpayer Protection and Repayment of Exchange Subsidy Overpayments Act of 2011; S 18, Small Business Paperwork Mandate Elimination Act; S 72, Small Business Paperwork Mandate Elimination Act.
*Medical Liability reform - HR 5, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011; S 197, MCAP Act; S 218, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011.
*Data Security - HR 611, BEST PRACTICES Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
*LTC insurance reforms - HR 63, Long-Term Care Insurance Reform Act of 2011; S 159, Confidence in Long-Term Care Insurance Act of 2011.
*Minimum hospital stays for matectomy patients - HR 111, Breast Cancer Patient Protection Act of 2011.
*National marketplace for individual coverage - HR 346, Health Care Choice Act of 2011; HR 371, Health Care Choice Act of 2011.
*Rate review - HR 416, Health Insurance Rate Review Act; S 137, Health Insurance Rate Review Act.
*Association health plans - HR 1050, Small Business Health Fairness Act of 2011.
*Antitrust policy - HR 1150, Competitive Health Insurance Reform Act of 2011.
*Agent commissions, medical loss ratios - HR 1206, Access to Professional Health Insurance Advisors Act of 2011.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
*Medicare Part D changes - HR 999, Medicare Prescription Drug Savings and Choice Act of 2011; S 560, Medicare Prescription Drug Savings and Choice Act of 2011.
*Medicare secondary payer rules - HR 1063, Strengthening Medicare And Repaying Taxpayers Act of 2011.
*Part D price negotiation - S 31, Prescription Drug and Health Improvement Act of 2011; S 44, Medicare Prescription Drug Price Negotiation Act of 2011.
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
*HSA improvements - HR 369, Health Savings and Affordability Act of 2011.
*Repeal of HSA restrictions - HR 524, Restoring Consumer-driven Health Care Act of 2011.
*Repeal of HSA and FSA restrictions - HR 450, Restoring Assistance for Families' and Seniors' Health Expenses Act of 2011; HR 605, Patients' Freedom to Choose Act;
S 312, Patients' Freedom to Choose Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
*FEHBP prescription drugs - HR 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act.
*Pay-for-delay settlements - S 27, Preserve Access to Affordable Generics Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Michael |
Berman |
|
|
|
Steven |
Champlin |
|
|
|
Kenneth |
Duberstein |
|
|
|
Brian |
Griffin |
|
|
|
Daniel |
Meyer |
|
|
|
Marti |
Thomas |
|
|
|
Eric |
Ueland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |